ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Rigid Hollow Microparticles for Enhanced Focused Ultrasound Treatment Under Optoacoustic Guidance.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The efficacy and safety of focused ultrasound (FUS) treatments can be significantly enhanced with microbubbles, but the common ultrasound contrast agents suffer from limited stability, short circulation times, and risks associated with inertial cavitation and jetting. Here, we demonstrate that rigid hollow microparticles enable controlled, targeted thermal treatments of deep tissues via FUS. These acoustically responsive agents exhibit properties comparable to microbubbles yet possess superior mechanical stability, prolonged circulation, and enhanced responsiveness. Characterized by a negative acoustic contrast factor, the hollow microparticles amplify FUS-induced effects-particularly localized hyperthermia-enabling precise, robust, and controllable thermal therapy. Tissue ablation experiments under optoacoustic imaging guidance demonstrate strong responsiveness to FUS, with histological analyses confirming a threefold increase in ablation volume compared with microparticle-free controls. Experimental and numerical results indicate that this enhanced efficacy arises from first-order acoustic effects and secondary mechanisms, including acoustic scattering and stable particle-to-particle interactions. Unlike microbubbles, hollow microparticles rely on non-cavitational heating, enabling predictable, dose-dependent thermal responses that improve safety and efficacy. The frequency-dependent response further highlights their multifunctional potential under varying acoustic conditions. These findings establish rigid hollow microparticles as stable, versatile acoustic agents that significantly advance the therapeutic scope and clinical utility of FUS therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.